Replies to post #84658 on NanoViricides Inc. (NNVC)

[Ubertino]

I would contact MHRA first, apply, or indicate an intention to do so, ask their advice and proceed from there.

Let's get the “Promising Innovative Medicine” (PIM) designation first!

Ref:
http://www.mhra.gov.uk/home/groups/comms-ic/documents/websiteresources/con392877.pdf
NICE
http://www.nice.org.uk/

[NewMoney]

Right now I think they just use it to kill lab rats so that seems a bit far fetched.

[Doctor_Hari_Seldon]

NNVC should keep all options open and query many of them on a fairly regular basis to keep abreast of any possible testing life-saving scenarios.

The UK relaxation is certainly a place to investigate. I am not sure if the viral types would be ones NNVC has more readily available or not. Once the Viroclinics data is in, it might be more clear what to try to have.

The one I don’t understand is rabies. There are people dying in South America and other places with a post symptomatic rabies infection that have no chance at all without a Nanovircide injection.

It is not just NNVC, other developmental theraputics have good potential to save lives in dire cases that are not used for legal and regulator reasons; Thus the UK position! It is nice to see the potential for such action widening.

BTW - Nice to see the price jump into a range that itches shorts!

[Echo20]

Another voice

That is being done.
Read Dr Seymour's letter to stockholders.

Echo20